214 related articles for article (PubMed ID: 21083023)
21. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
[TBL] [Abstract][Full Text] [Related]
22. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
Gurney JG; Ness KK; Rosenthal J; Forman SJ; Bhatia S; Baker KS
Cancer; 2006 Mar; 106(6):1402-8. PubMed ID: 16453335
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
[TBL] [Abstract][Full Text] [Related]
24. Bronchiolitis obliterans following hematopoietic stem cell transplantation: a clinical update.
Pandya CM; Soubani AO
Clin Transplant; 2010; 24(3):291-306. PubMed ID: 19849704
[TBL] [Abstract][Full Text] [Related]
25. Late complications in blood and marrow transplant survivors.
Majhail NS
Minn Med; 2010 Oct; 93(10):45-9. PubMed ID: 21140762
[TBL] [Abstract][Full Text] [Related]
26. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
[TBL] [Abstract][Full Text] [Related]
27. Critical care considerations of hematopoietic stem cell transplantation.
Soubani AO
Crit Care Med; 2006 Sep; 34(9 Suppl):S251-67. PubMed ID: 16917431
[TBL] [Abstract][Full Text] [Related]
28. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
30. Endocrinological late complications after hematopoietic SCT in children.
Cohen A; Békássy AN; Gaiero A; Faraci M; Zecca S; Tichelli A; Dini G;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S43-8. PubMed ID: 18545244
[TBL] [Abstract][Full Text] [Related]
31. Early central nervous system complications after reduced-intensity stem cell transplantation.
Kishi Y; Miyakoshi S; Kami M; Ikeda M; Katayama Y; Murashige N; Kusumi E; Yuji K; Kobayashi K; Kato D; Hamaki T; Matsumura T; Kim SW; Morinaga S; Mori S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S;
Biol Blood Marrow Transplant; 2004 Aug; 10(8):561-8. PubMed ID: 15282534
[TBL] [Abstract][Full Text] [Related]
32. Endocrine complications of hematopoietic stem cell transplantation.
Chemaitilly W; Sklar CA
Endocrinol Metab Clin North Am; 2007 Dec; 36(4):983-98; ix. PubMed ID: 17983932
[TBL] [Abstract][Full Text] [Related]
33. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
Bacigalupo A; Chien J; Barisione G; Pavletic S
Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
[TBL] [Abstract][Full Text] [Related]
34. Managing the toxicity of hematopoietic stem cell transplant.
Pallera AM; Schwartzberg LS
J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824
[TBL] [Abstract][Full Text] [Related]
35. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
36. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
37. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
38. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
39. Haematopoietic stem cell transplantation: current status.
Kumar L
Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617
[TBL] [Abstract][Full Text] [Related]
40. Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]